SCHEMBL6708767

SCHEMBL6708767

CC(=O)Nc1ccc(-c2cc3onc(C(=O)Nc4ccc(Cl)cc4-c4nnn[nH]4)c3cc2NC(C)=O)c(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 4/20 0.35
TMPRSS4 Q9NRS4 4/20 0.33
MAP2K1 Q02750 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
HDAC1 Q13547 1/20 0.32
KDM4E B2RXH2 1/20 0.32
RAB9A P51151 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
GRM4 Q14833 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EEF2K O00418 1/20 0.31
PLK1 P53350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6753986 0.90 RORC (0.32) MAP2K1S1PR1S1PR3TP53MAPT
SCHEMBL6707946 0.87 GRIK1 (0.42) HIF1ATMPRSS4MAP2K1TRPV1HDAC1
SCHEMBL6710266 0.86 HIF1A (0.44) HIF1AHDAC1KDM4ERAB9ASMN1; SMN2
SCHEMBL7129851 0.81 LMNA (0.36) HIF1ARAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL6708056 0.79 HIF1A (0.46) HIF1AKDM4E
SCHEMBL6710154 0.79 GRIK1 (0.40) HIF1AMAP2K1HDAC1S1PR1S1PR3
SCHEMBL6709945 0.79 HIF1A (0.40) HIF1AKDM4ERAB9ACYP1A2CYP2D6
SCHEMBL6710221 0.79 EPHX2 (0.43) HIF1AKDM4ERAB9ACYP1A2CYP2D6
SCHEMBL6833746 0.77 KCNK2 (0.39) HIF1AMAP2K1KDM4ES1PR1S1PR3
SCHEMBL6833974 0.77 TAS2R14 (0.42) HIF1AMAP2K1CA12CA9GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885TMPRSS4 1291/4885MAP2K1 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.